First, the sample size used for the survival analysis was not large enough, which led to many false‐negative results regarding PLCD1 and PLCD4, especially since PLCD1 has been shown to inhibit pancreatic cancer cell growth in other studies. The gene discussed is PLCD4; the disease is familial pancreatic carcinoma.